One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3weeks
Sample Provided: yes
Payment Terms: T/T
LL-37 is the only antibacterial peptide in vivo that can neutralize endotoxin. In vitro, LL-37 can prevent endotoxin from binding to macrophages and inhibit endotoxin-induced tumor necrosis factor-α (TNF-α) expression. In animal simulation experiments, LL-37 can reduce the mortality of endotoxin shock model rats, mainly because LL-37 can combine with the negatively charged groups in endotoxin, inhibit the toxic transformation of endotoxin, and eliminate The effect of toxin biological activity. LL-37 (37-1) is a peptide with the reverse sequence of LL-37. It consists of 37 amino acids and has similar biological functions.
Audited Supplier
Pharma Sources Insight January 2025
